$5.58
Market Cap
$241.84M
Shares Outstanding
43.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 19, 2025
Round Lot
100
Locale
US
Day Open
$5.54
Day High
$5.77
Day Low
$5.42
Volume
278.1K
VWAP
$5.58
Prev Close
$5.51
Transactions
--
Acc. Volume
--
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Anbio Biotechnology Class A Ordinary Shares (NNNN) closed the 2026-09-16 session at $5.58, up 1.27% versus the previous close (+0.07). The stock opened at $5.54 and traded between $5.42 and $5.77 during that session. Session trading volume was 278K shares. The volume-weighted average price (VWAP) is $5.58.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Anbio Biotechnology Class A Ordinary Shares has a market capitalization of $241.8 million. NNNN is listed on the XNAS exchange. The company employs approximately 27 people. The recorded listing date is 2025-02-19.
On this page you can find market NNNN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.